Go Pro
→ Washington Is Broke—Could YOUR Savings Be Next? (From Priority Gold) (Ad)tc pixel Free JSPR Stock Alerts

Jasper Therapeutics (JSPR) Institutional Ownership

Jasper Therapeutics logo
$0.60 +0.03 (+5.77%)
As of 11:34 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Jasper Therapeutics (NASDAQ:JSPR)

Current
Institutional Ownership
Percentage
79.85%
Number of
Institutional Buyers
(last 12 months)
24
Total
Institutional Inflows
(last 12 months)
$24.77M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$1.71M
Get JSPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

JSPR Institutional Buying and Selling by Quarter

Jasper Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026 Renaissance Technologies LLC177,500$156K0.0%-21.9%0.634%
5/14/2026 Knott David M Jr160,789$141K0.1%-11.4%0.574%
2/19/2026 T. Rowe Price Investment Management Inc.964,754$1.77M0.0%-6.2%3.448%
2/18/2026 Sphera Funds Management LTD.485,401$888K0.2%-22.9%1.735%
2/18/2026 Quadrature Capital Ltd67,267$123K0.0%N/A0.240%
2/18/2026 Millennium Management LLC1,073,783$1.97M0.0%+194.2%3.838%
2/18/2026 Engineers Gate Manager LP14,257$26K0.0%N/A0.051%
2/18/2026 Boothbay Fund Management LLC793,954$1.45M0.0%+79.4%2.838%
2/17/2026 ADAR1 Capital Management LLC140,000$256K0.0%N/A0.500%
2/17/2026 Jain Global LLC43,301$79K0.0%N/A0.155%
2/17/2026 T. Rowe Price Investment Management Inc.385,522$706K0.0%-62.5%1.378%
2/16/2026 Squarepoint Ops LLC281,926$516K0.0%+1,919.5%1.008%
2/16/2026 Panagora Asset Management Inc.19,362$35K0.0%N/A0.069%
2/13/2026 Quarry LP99,529$182K0.0%N/A0.356%
2/12/2026 Renaissance Technologies LLC227,183$416K0.0%+9.0%0.812%
2/12/2026 Dimensional Fund Advisors LP18,664$34K0.0%-52.1%0.067%
2/12/2026 Knott David M Jr181,389$332K0.2%+5.8%0.648%
2/10/2026 Goldman Sachs Group Inc.1,746,492$3.20M0.0%+6,394.9%6.241%
2/9/2026 Geode Capital Management LLC211,857$388K0.0%+61.9%0.757%
11/17/2025 Armistice Capital LLC348,000$828K0.0%N/A2.141%
11/17/2025 Acorn Capital Advisors LLC1,382,640$3.29M1.7%N/A8.507%
11/17/2025 Woodline Partners LP1,039,751$2.48M0.0%N/A6.397%
11/17/2025 Voleon Capital Management LP20,950$50K0.0%N/A0.129%
11/17/2025 Velan Capital Investment Management LP2,668,395$6.21M5.8%+86.1%16.418%
11/17/2025 Millennium Management LLC364,939$869K0.0%+151.3%2.245%
11/17/2025 Kingdon Capital Management L.L.C.1,324,845$3.15M0.4%+93.5%8.151%
11/17/2025 Boothbay Fund Management LLC442,642$1.05M0.0%N/A2.723%
11/14/2025 Two Sigma Investments LP40,427$96K0.0%N/A0.249%
11/14/2025 Squarepoint Ops LLC13,960$33K0.0%-45.0%0.086%
11/13/2025 Knott David M Jr171,389$408K0.2%N/A1.055%
11/12/2025 Propel Bio Management LLC1,028,806$2.45M2.5%N/A6.331%
11/12/2025 Dimensional Fund Advisors LP38,963$93K0.0%-12.8%0.240%
11/7/2025 Readystate Asset Management LP98,439$234K0.0%N/A0.606%
11/7/2025Vanguard Group Inc.1,032,842$2.46M0.0%+65.4%6.356%
10/20/2025 Simplify Asset Management Inc.609,053$1.45M0.0%N/A3.748%
10/17/2025 Sowell Financial Services LLC10,400$25K0.0%-39.9%0.064%
8/19/2025 Marex Group plc13,300$74K0.0%N/A0.089%
8/15/2025 Engineers Gate Manager LP13,972$78K0.0%N/A0.093%
8/15/2025 Bank of America Corp DE293,460$1.63M0.0%-18.6%1.954%
8/14/2025 Jane Street Group LLC132,905$738K0.0%N/A0.885%
$20,000 gold before year end? (Ad)

President Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and America's $40 trillion national debt to a potential surge in gold prices, with some forecasts pointing to $10,000 or even $20,000 gold. Dr. David Eifrig, a 40-year market veteran and former Goldman Sachs Vice President, says an unusual plan involving Trump and two other top officials could fuel the biggest gold bull run in decades. Eifrig has shared his top gold pick tied to this developing story.tc pixel

Read the full gold report and see Eifrig's top pick now
8/13/2025 Marshall Wace LLP50,686$281K0.0%N/A0.337%
8/12/2025 XTX Topco Ltd27,348$152K0.0%N/A0.182%
8/12/2025 JPMorgan Chase & Co.65,088$361K0.0%+1,074.7%0.433%
8/8/2025 Geode Capital Management LLC131,130$728K0.0%-50.3%0.873%
8/5/2025Corton Capital Inc.10,004$56K0.1%-62.1%0.067%
8/5/2025 Bank of Montreal Can158,133$878K0.0%+120.4%1.053%
7/14/2025 Sowell Financial Services LLC17,303$96K0.0%-16.9%0.115%
6/27/2025 Goldman Sachs Group Inc.233,758$1.01M0.0%+11.2%1.556%
5/21/2025Acadian Asset Management LLC10,708$46K0.0%N/A0.071%
5/16/2025Goldman Sachs Group Inc.233,758$1.01M0.0%+11.2%1.556%
5/15/2025Kingdon Capital Management L.L.C.490,000$2.11M0.2%+9.6%3.262%
5/14/2025T. Rowe Price Investment Management Inc.702,757$3.02M0.0%+755.3%4.678%
5/12/2025Nuveen LLC102,268$440K0.0%N/A0.681%
5/9/2025Charles Schwab Investment Management Inc.26,648$115K0.0%-17.6%0.177%
5/7/2025Corton Capital Inc.26,382$113K0.4%N/A0.176%
4/17/2025Sowell Financial Services LLC20,825$90K0.0%-25.7%0.139%
3/24/2025Wellington Management Group LLP27,069$579K0.0%+13.9%0.180%
2/27/2025Jefferies Financial Group Inc.31,250$668K0.0%N/A0.208%
2/17/2025Woodline Partners LP245,676$5.25M0.0%-50.4%1.638%
2/17/2025Soleus Capital Management L.P.1,494,420$31.95M2.0%+11.2%9.962%
2/17/2025Tema Etfs LLC12,435$266K0.1%N/A0.083%
2/17/2025Stempoint Capital LP135,244$2.89M0.7%N/A0.902%
2/17/2025Integral Health Asset Management LLC650,000$13.90M1.2%+85.7%4.333%
2/17/2025Jefferies Financial Group Inc.31,250$668K0.0%N/A0.208%
2/17/2025Deutsche Bank AG170,695$3.65M0.0%+30.0%1.138%
2/17/2025Braidwell LP714,658$15.28M0.5%+47.9%4.764%
2/17/2025Bank of America Corp DE287,204$6.14M0.0%-11.9%1.915%
2/17/2025Allostery Investments LP22,000$470K0.5%N/A0.147%
2/17/2025Ally Bridge Group NY LLC122,424$2.62M2.2%-69.4%0.816%
2/14/2025Boxer Capital Management LLC350,000$7.48M0.6%N/A2.333%
2/14/2025Jane Street Group LLC10,852$232K0.0%-18.7%0.072%
2/14/2025Northern Trust Corp104,367$2.23M0.0%-2.4%0.696%
2/14/2025Propel Bio Management LLC20,000$428K0.4%N/A0.133%
2/14/2025T. Rowe Price Investment Management Inc.82,165$1.76M0.0%N/A0.548%
2/14/2025Rock Springs Capital Management LP463,088$9.90M0.4%+0.9%3.087%
2/13/2025Marshall Wace LLP77,722$1.66M0.0%+17.2%0.518%
2/13/2025Mariner LLC36,794$787K0.0%-12.8%0.245%
2/13/2025Barclays PLC18,334$392K0.0%+13.6%0.122%
2/13/2025Russell Investments Group Ltd.247,272$5.29M0.0%+16.9%1.648%
2/13/2025Wells Fargo & Company MN7,415$159K0.0%+106.7%0.049%
2/12/2025Wellington Management Group LLP27,069$579K0.0%+13.9%0.180%
2/12/2025Schroder Investment Management Group59,034$1.24M0.0%N/A0.394%
2/12/2025JPMorgan Chase & Co.5,165$110K0.0%-68.5%0.034%
2/11/2025EntryPoint Capital LLC10,431$223K0.1%N/A0.070%
2/11/2025Simplify Asset Management Inc.20,000$428K0.0%N/A0.133%
1/30/2025Rhumbline Advisers14,761$316K0.0%+12.6%0.098%
12/26/2024JPMorgan Chase & Co.16,391$308K0.0%+239.8%0.109%
11/27/2024Franklin Resources Inc.579,636$10.90M0.0%-17.0%3.864%
11/19/2024Barclays PLC16,146$304K0.0%+320.7%0.108%
11/16/2024Geode Capital Management LLC257,416$4.84M0.0%-0.9%1.704%
$40,000,000,000,000 (Ad)

The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its entire military budget. Central banks have bought over 1,000 tonnes of gold a year for three years running, trading paper for metal.tc pixel

See what the money printers see - download the free 2026 Wealth Protection Guide
11/15/2024Barclays PLC16,146$304K0.0%+320.7%0.107%
11/15/2024Jane Street Group LLC13,354$251K0.0%N/A0.088%
11/15/2024Wellington Management Group LLP23,759$447K0.0%N/A0.157%
11/15/2024State Street Corp214,883$4.04M0.0%+12.3%1.423%
11/15/2024Samsara BioCapital LLC584,642$11.00M2.1%+11.4%3.872%
11/15/2024Ikarian Capital LLC55,175$1.04M0.1%-47.5%0.365%
11/14/2024Braidwell LP483,300$9.09M0.3%N/A3.201%
11/14/2024Verition Fund Management LLC25,353$477K0.0%N/A0.168%
11/14/2024Ally Bridge Group NY LLC399,466$7.51M4.0%+82.7%2.645%
11/14/2024MetLife Investment Management LLC6,874$129K0.0%+129.1%0.046%


JSPR Institutional Ownership - Frequently Asked Questions

During the previous two years, 71 institutional investors and hedge funds held shares of Jasper Therapeutics. The most heavily invested institutionals were Soleus Capital Management L.P. ($31.95M), Braidwell LP ($15.28M), Integral Health Asset Management LLC ($13.90M), Samsara BioCapital LLC ($11.00M), Franklin Resources Inc. ($10.90M), Rock Springs Capital Management LP ($9.90M), and Boxer Capital Management LLC ($7.48M).Learn more on Jasper Therapeutics' institutional investors.

79.85% of Jasper Therapeutics' stock is owned by institutional investors. Learn more on JSPR's institutional investor holdings.

Of the 61 institutional investors that purchased Jasper Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Goldman Sachs Group Inc. ($1.77M), Acorn Capital Advisors LLC ($1.38M), Velan Capital Investment Management LP ($1.23M), Propel Bio Management LLC ($1.05M), Woodline Partners LP ($1.04M), Millennium Management LLC ($928.56K), and Boothbay Fund Management LLC ($793.95K).

Institutional investors have bought a total of 11,225,892 shares in the last 24 months. This purchase volume represents approximately $24.77M in transactions.

The following institutional investors have sold Jasper Therapeutics stock in the last 24 months: T. Rowe Price Investment Management Inc. ($707.34K), Sphera Funds Management LTD. ($144.07K), Renaissance Technologies LLC ($49.68K), Dimensional Fund Advisors LP ($26.00K), Knott David M Jr ($20.60K), Squarepoint Ops LLC ($11.42K), and Sowell Financial Services LLC ($6.90K).

Institutional investors have sold a total of 966,007 shares in the last 24 months. This volume of shares sold represents approximately $1.71M in transactions.


Related Companies

Institutional ownership data for NASDAQ:JSPR is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 5/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners
“This is the Perfect Tech Stock”
Jeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...
Brownstone Research | Sponsoredtc pixel
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...
TradeSmith | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
Gold just passed our debt as the world's #1 asset
China's US Treasury holdings have fallen from a peak of $1.32 trillion to roughly $659 billion, an 18-year low...
Behind the Markets | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
NNVC on Alert: FDA Validation and Outperform Rating!
NanoViricides (NYSE: NNVC) just landed FDA Rare Pediatric Disease Designation for NV-387 in Measles, adding to...
Equiscreen | Sponsoredtc pixel
What Is A Roth Conversion, And How Do I Set One Up?
A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax t...
SmartAsset | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel